Dopamine partial agonists: A new class of antipsychoticLIEBERMAN, Jeffrey A.CNS drugs. 2004, Vol 18, Num 4, pp 251-267, issn 1172-7047, 17 p.Article

New Antipsychotic Drugs: Special Issues and IndicationsBREIER, Alan; LIEBERMAN, Jeffrey A.Schizophrenia research. 1999, Vol 35, issn 0920-9964, 110 p., SUPConference Proceedings

Getting the Facts Straight About Gun Violence and Mental Illness: Putting Compassion Before FearFISHER, Carl E; LIEBERMAN, Jeffrey A.Annals of internal medicine. 2013, Vol 159, Num 6, pp 423-424, issn 0003-4819, 2 p.Article

Clinical experience with olanzapine, a new atypical antipsychoticWOOD, A.International clinical psychopharmacology. 1998, Vol 13, pp S59-S62, issn 0268-1315, SUP1Conference Paper

The NIMH-CATIE ProjectLIEBERMAN, Jeffrey A; STROUP, T. Scott.Schizophrenia bulletin. 2003, Vol 29, Num 1, issn 0586-7614, 178 p.Serial Issue

Subjective experiences of schizophrenic patients treated with antipsychotic medicationNABER, D.International clinical psychopharmacology. 1998, Vol 13, pp S41-S45, issn 0268-1315, SUP1Conference Paper

Generating evidence to inform policy and practice: The example of the second generation atypical antipsychoticsQEDDES, John.Schizophrenia bulletin. 2003, Vol 29, Num 1, pp 105-114, issn 0586-7614, 10 p.Article

First psychotic episode in schizophrenia. CongressLINSZEN, Donald H; LIEBERMAN, Jeffrey A.International clinical psychopharmacology. 1998, Vol 13, issn 0268-1315, 111 p., SUP1Conference Proceedings

Prolactin and antipsychotic medications : mechanism of actionPETTY, R. G.Schizophrenia research. 1999, Vol 35, pp S67-S73, issn 0920-9964, SUPConference Paper

Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophreniaREVICKI, D. A.Schizophrenia research. 1999, Vol 35, pp S101-S109, issn 0920-9964, SUPConference Paper

Tardive dyskinesia and atypical antipsychotic drugsCASEY, D. E.Schizophrenia research. 1999, Vol 35, pp S61-S66, issn 0920-9964, SUPConference Paper

Attentional modulation of early-stage visual processing in schizophreniaVAN DER STELT, Odin; LIEBERMAN, Jeffrey A; BELGER, Aysenil et al.Brain research. 2006, Vol 1125, pp 194-198, issn 0006-8993, 5 p.Article

Oxytocin, Dopamine, and the Amygdala: A Neurofunctional Model of Social Cognitive Deficits in SchizophreniaROSENFELD, Andrew J; LIEBERMAN, Jeffrey A; JARSKOG, L. Fredrik et al.Schizophrenia bulletin. 2011, Vol 37, Num 5, pp 1077-1087, issn 0586-7614, 11 p.Article

Use of quetiapine in children and adolescentsFINDLING, Robert L.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 13, pp 27-31, 5 p.Article

Predictive symptomatology, course and outcome in first-episode schizophreniaJOHNSTONE, E. C.International clinical psychopharmacology. 1998, Vol 13, pp S97-S99, issn 0268-1315, SUP1Conference Paper

Adolescent behavioral and intrafamilial precursors of schizophrenia spectrum disordersGOLDSTEIN, M. J.International clinical psychopharmacology. 1998, Vol 13, issn 0268-1315, p. S101, SUP1Conference Paper

Measurement of brain metabolites by ¹H magnetic resonance spectroscopy in patients with schizophrenia : A systematic review and meta-analysisSTEEN, R. Grant; HAMER, Robert M; LIEBERMAN, Jeffrey A et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 11, pp 1949-1962, issn 0893-133X, 14 p.Article

Pathophysiology in the clinical course of schizophreniaLIEBERMAN, J. A.International clinical psychopharmacology. 1998, Vol 13, pp S3-S6, issn 0268-1315, SUP1Conference Paper

Perinatal flunitrazepam exposure causes persistent alteration of parvalbumin-immunoreactive interneuron localization in rat prefrontal cortexGROBIN, A. Chistina; LIEBERMAN, Jeffrey A; MORROW, A. Leslie et al.Neuroscience letters. 2004, Vol 359, Num 1-2, pp 9-12, issn 0304-3940, 4 p.Article

Extrapyramidal syndromes and new antipsychotic drugs : Findings in patients and non-human primate modelsCASEY, D. E.British journal of psychiatry. Supplement. 1996, Vol 168, Num 29, pp 32-39, issn 0960-5371Article

Myocarditis during clozapine treatmentMERRILL, David B; AHMARI, Susanne E; BRADFORD, Jean-Marie E et al.The American journal of psychiatry. 2006, Vol 163, Num 2, pp 204-208, issn 0002-953X, 5 p.Article

Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugsROSENHECK, Robert; DOYLE, Jefferson; LESLIE, Douglas et al.Schizophrenia bulletin. 2003, Vol 29, Num 1, pp 81-93, issn 0586-7614, 13 p.Article

Science to services: Consumers need real-world scienceAMADOR, Xavier F; FITZPATRICK, Michael.Schizophrenia bulletin. 2003, Vol 29, Num 1, pp 133-137, issn 0586-7614, 5 p.Article

Hypothesis and hypothesis testing in the clinical trialLIEBERMAN, Jeffrey A; LIEBERMAN; KANE et al.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 9, pp 5-10Conference Paper

The early phase of schizophrenia and prediction of outcomeGROSS, G; HUBER, G; KLOSTERKÖTTER, J et al.International clinical psychopharmacology. 1998, Vol 13, pp S13-S21, issn 0268-1315, SUP1Conference Paper